Heights Capital Management’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$265K Sell
163,728
-147,488
-47% -$454K 0.05% 194
2026
Q2
$1.6M Buy
+311,216
New +$1.1M 0.37% 79

Other funds holding CALC

Heights Capital Management's CALC Position: Q3 2026 in Review

Heights Capital Management reduced its CalciMedica (CALC) stake by 47% in Q3 2026, selling an estimated $454K and leaving 163,728 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #194.

Heights Capital Management first reported a position in CALC in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.6M in Q2 2026. 17 funds tracked by Wall St. Rank hold CALC as of Q3 2026.

  • Heights Capital Management held 163,728 shares of CalciMedica worth $265K as of Q3 2026.
  • Heights Capital Management sold 147,488 CalciMedica shares in Q3 2026, an estimated $454K.
  • CalciMedica made up 0.05% of Heights Capital Management's portfolio in Q3 2026, its #194 holding.
  • Heights Capital Management first reported a position in CalciMedica in Q2 2026 and has held it in 2 quarters since.
  • Heights Capital Management's CalciMedica position peaked at $1.6M in Q2 2026.
  • 17 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.

Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.